The class action is brought on behalf of all persons or entities that purchased or otherwise acquired Sotera common stock: (i) pursuant and/or traceable to the Company’s initial public offering conducted on or around November 20, 2020 (the “IPO”); (ii)
pursuant and/or traceable to the Company’s secondary public offering conducted on or around March 18, 2021 (the “SPO,” and together with the IPO, the “Offerings”); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). This action is to recover damages.
On the governance action: Current long-term Sotera shareholders who have held Sotera stock: (i) pursuant and/or traceable to the Company’s initial public offering conducted on or around November 20, 2020 (the “IPO”) or (ii) pursuant and/or traceable to the Company’s secondary public offering conducted on or around March 18, 2021 can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.
If you would like to learn more about this matter, you are encouraged to contact at jgrabar @FH-6085.
Recent SHC News
- Sotera Health Reports First-Quarter 2024 Results • GlobeNewswire Inc. • 05/02/2024 11:00:34 AM
- Sotera Health Announces First-Quarter 2024 Earnings Release Date • GlobeNewswire Inc. • 04/11/2024 08:00:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:54:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:35:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:24:12 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 02/29/2024 10:03:02 PM
- Sotera Health Announces Pricing of Secondary Offering • GlobeNewswire Inc. • 02/28/2024 11:40:11 PM
- Sotera Health Announces Secondary Offering of Common Stock • GlobeNewswire Inc. • 02/27/2024 10:30:11 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 02/27/2024 10:24:46 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/27/2024 10:06:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:13:42 PM
- Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook • GlobeNewswire Inc. • 02/27/2024 12:00:53 PM
- Sotera Health Announces Fourth-Quarter and Full-Year 2023 Earnings Release Date • GlobeNewswire Inc. • 02/15/2024 12:00:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 12:18:05 PM
- Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/09/2024 12:00:48 PM
- Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 12:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 10:18:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:08:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:29:55 PM
- Sotera Health Appoints Karen Flynn to Board of Directors • GlobeNewswire Inc. • 11/13/2023 12:00:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 08:53:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 11:12:24 AM
- Sotera Health Reports Third-Quarter and Year-to-Date 2023 Results • GlobeNewswire Inc. • 11/01/2023 11:00:35 AM
- Sotera Health Announces Third-Quarter 2023 Earnings Release Date • GlobeNewswire Inc. • 10/18/2023 11:00:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:56:47 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM